Sanofi Recalls Subpotent Rifadin Rifampin Capsules Due to Low Fill Volume
Sanofi US is recalling 2,462 bottles of Rifadin (Rifampin) 150 mg capsules because some capsules contain low fill volume, resulting in subpotent drug.
- Product
- Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30
- Category
- Drug
- Distribution
- Distributed nationwide